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ABSTRACT
Environmental quality is a major factor in global health that mainly affects the poorest populations. Vector-
borne diseases, climate change, pollution and unintentional poisonings are recognized as the primary causes of 
environmental diseases burden in developing countries. The development and implementation of new technologies 
to reduce the impact of these risk factors on health in developing countries is a priority in the current research. 
In this regard, synthetic biology, a nearly new research area, has initiated a big revolution through the de novo 
design or rewiring of biological components, organisms, and functions with the aim to reduce the adverse effects of 
environmental risk factors on human health. Despite synthetic biology is well recognized for being a multidisciplinary 
area where biotechnologist, biologist, physicists, mathematicians and engineers play together, its integration with 
public health and other social sciences seems to be of relevance to apply these technologies into a practical context. 
In this review, we discuss the major advances in synthetic biology with potential to improve environmental quality 
and human health in developing countries.
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RESUMEN
La calidad ambiental es reconocida como uno de los factores con mayor impacto sobre la salud humana principalmente 
en los países en vías de desarrollo. Las enfermedades transmitidas por vectores, el cambio climático, la contaminación 
y las intoxicaciones no intencionales han sido reportados como las principales causas de enfermedades ambientales 
en estos países. El desarrollo y la implementación de nuevas tecnologías encaminadas a reducir el impacto de estos 
factores ambientales en la salud es una prioridad de la investigación actual. En ese sentido, la biología sintética ha 
iniciado una gran revolución al permitir el diseño de novo y el mejoramiento de diversos componentes biológicos, 
organismos y funciones biológicas que tienen el potencial de reducir los efectos adversos de estos factores en la 
salud humana de una manera más eficiente y económica. A pesar de que la biología sintética es reconocida como 
un área multidisciplinaria donde biotecnólogos, biólogos, físicos, matemáticos e ingenieros unen sus esfuerzos, su 
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integración con el área de la salud pública y las ciencias sociales es muy importante para llevar estas tecnologías a 
la práctica. En esta revisión, nosotros discutimos los más importantes avances en biología sintética y su potencial 
para mejorar la calidad ambiental y la salud humana en países en vías de desarrollo.
Keywords: Salud pública. Biología Sintética. Países en vías de desarrollo. Enfermedades ambientales. 
INTRODUCTION
Almost 20 years ago, the role of the environmental 
quality as a determinant of human ill health was well-
described by Kirk Smith and co-workers1. In their work 
summarized in the WHO 1997 report “Health and 
Environment in Sustainable Development,” the authors 
attempted to establish a set of standard definitions and 
categories that were used over the last two decades 
to study how much the environmental factors are 
contributing to ill health. A formal definition of the terms 
“environment,” “ill health” and “attributable” as well a 
defined number of diseases categories and environmental 
risk factors were provided and implemented to estimate 
the effect of several environment risk factor on the 
global ill health. The authors suggested that one-quarter 
to one-third of ill health in the world at that time was 
attributable to environmental factors1. Nevertheless, 
they also recognized that further collection of high-
quality global data related to the environmental health 
impact was needed to dissect this estimation properly.
During the past two decades, several studies were 
subsequently performed with the aim to increase 
the amount and quality of these data. Most of them 
implemented new tools for epidemiologic analysis, 
which resulted in more accurate methods for estimating 
the impact of the environmental factors on heath. A 
summary of these studies was published in 2008 by 
Prüss-Üstün and co-workers2. Authors performed 
a meta-synthesis analysis in order to integrate the 
results from a number of different studies originated 
in the various countries. In that way, the impact of 
several environmental factors on health was analyzed 
country-wise2. A total of 192 countries profiles were 
studied and data confirmed the previous hypothesis 
that environmental quality is a major factor in health 
that mainly affects the poorest populations1. People in 
developing countries have a higher risk due to the poor 
environmental quality2.
Nowadays, the United Nations Environment Programme 
(UNEP) and the World Health Organization (WHO) 
have established an initiative to facilitate and enhance 
effective actions in developing countries that can reduce 
the adverse environmental impact on human health. 
This initiative called “The Health, and Environment 
Linkages” (HELI) has provided support to several 
developing countries focused on the major areas of risk 
defined in Table 1.
The development and implementation of new 
technologies to reduce the impact of these risk factors 
on health in developing countries is a priority in the 
current research (Table 1). In this regard, Synthetic 
Biology, a nearly new research area, has given a big 
step through the design of biological systems with the 
potential to reduce the adverse effects of environmental 
risk factors on human health. This nascent discipline 
has been extensively described and refers to a variety 
of experimental approaches (the product of interactive 
cycles of computer modeling, biology assembly, 
and testing) aimed to modify or mimic biological 
systems15-20. In this review, we describe the major 
advances in synthetic biology with a highly potential 
to improve environmental quality and human health in 
developing countries.
Table 1. Priority causes of environmental diseases burden in 
developing countries
Area of risk Deaths globally per year Reference
Vector-borne 
diseases
Malaria ~1.2 million (3)
Leishmaniasis ~30 000 (4)
Dengue ~10 000 (5)
Climate change 
impacts ~150 000
(6)
(7)
Poor water 
quality
Diarrheal diseases ~3 
millions
(8)
Intestinal helminths ~100 
000
Schistosomiasis ~200 000
Trypanosomiasis ~130000
Poor urban and 
indoor air quality
Indoor smoke ~1.6 million
(9-10)
Urban air pollution 800 000
Unintentional 
poisonings
~585 000 (355 000 
associated with exposure 
to toxic chemicals and 
pesticides and 230 000 
associated to lead exposure)
(11-14)
95
The potential of synthetic biology for improving environmental quality and human health in developing countries
Synthetic Biology and human health
According to König et al., synthetic biology can 
be defined as a rational approach to design new 
biological components, organisms, and functions 
that do not exist in nature or to redesign existing 
biological systems to satisfy human needs21. One of 
the most remarkable examples of the potential of 
synthetic biology in human health is the development 
of the semi-synthetic antimalarial drug artemisinin. 
Artemisinin, a sesquiterpene lactone endoperoxide 
extracted from the sweet wormwood plant (Artemisia 
annua) whose discovery was awarded the 2015 Nobel 
Prize is known to be very efficient against multidrug-
resistant Plasmodium spp22. This compound has been 
traditionally obtained from 8 months A. annua plants 
using well-described extraction methods23. For years, 
China and Vietnam lead the global production of this 
plant and more farmers around the world started to 
plant it due to its role in malaria treatment. However, its 
production was not enough to meet the demand, which 
made this drug unaffordable to most malaria sufferers 
as reported by Martin Enserink in 200524. Just one year 
after Enserink`s report, scientists from the University of 
California (Berkeley) published their 2006 Nature paper 
entitled “Production of the antimalarial drug precursor 
artemisinic acid in engineered yeast.” Authors 
successfully engineered Saccharomyces cerevisiae to 
produce high titers of artemisinic acid (the immediate 
artemisinin precursor) in a cost-effective, eco-friendly 
and high-quality way25. First, the authors engineered the 
farnesyl pyrophosphate (FPP) biosynthetic pathway in 
order to increase the production of FPP and decrease its 
use for sterols by upregulating the expression of several 
genes in the FPP synthesis and downregulated those 
genes involved in FPP conversion to sterols. Then, they 
introduced and expressed the amorphadiene synthase 
gene (ADS) from the plant A. annua in S. cerevisiae to 
convert the FPP to amorphadiene. Finally, they cloned 
and expressed a novel cytochrome P450 from A. annua 
in S. cerevisiae that performs a three-step oxidation of 
amorphadiene to artemisinic acid25. Authors were able 
to engineered S. cerevisiae and subsequently produce 
artemisinic acid in a process with a higher specific 
productivity as compared to A. annua-based process 
using several synthetic biology approaches.
Only two years ago, in 2014, the production of 
artemisinic acid at industrial scale became real when 
a consortium within a synthetic biology company 
(Amyris, University of California, Berkeley) and 
the pharmaceutical firm Sanofi started to sell semi-
synthetic artemisinin made in genetically engineered 
yeast. They described this achievement as “a crucial 
breakthrough in anti-malaria efforts, particularly 
in terms of affordability and access for the poor.” 
However, after two years in the market, the impact of 
the first commercial deployment of synthetic biology is 
very low, and there is still a long way to produce enough 
semi-synthetic artemisinin to replace the agriculturally 
produced26. 
Similar studies have been conducted to engineer 
Escherichia coli for artemisinic acid production27, to 
express synthetic human neutralizing antibodies against 
various dengue virus28, to construct a synthetic circuit 
for the enzyme inositol phosphoryl ceramide synthase in 
Leishmania29 and to genetically-engineer Aedes aegypti 
mosquitoes to control the transmission of dengue30. All 
these examples show how synthetic biology approaches 
(based on cost-effective and eco-friendly technologies) 
can be used to improve the treatment of the major vector-
borne diseases in developing countries. Nevertheless, 
as it was shown in the case of the artemisinin, an 
effective implementation of such technologies is a long 
and complex process, too long, that semi-synthetic 
artemisinin commercialization was concomitant with 
the observation of widespread artemisinin resistance 
across Southeast Asia31. In general, the complete 
process involves several phases of modeling and 
design, genetic and metabolic engineering, functional 
analysis, downstream processing, industrial application 
and marketing.
Despite Synthetic biology is well recognized for being a 
multidisciplinary area where biotechnologist, biologist, 
physicists, mathematicians and engineers play together, 
its integration with public health and other social sciences 
seems to be of relevance to rush the implementation of 
these technologies into a practical context.
Synthetic biosensors and environmental quality
Microbial bioindicators have been traditionally used for 
decades in order to estimate the altered environmental 
conditions and identify and quantify the effect of different 
pollutants in the environment32-33. Microorganisms have 
been mainly selected as bioindicators because they can 
be found in large quantities, which makes easier its 
detection and sampling. In addition, they contain a high 
number of quantifiable phenotypes induced by a large 
number of environmental alterations. There are several 
examples of bioindicators used to determine the quality 
of soil33, water32 and air34.
Several advances in genetic and metabolic engineering 
during last two decades shifted the traditional use 
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of microbial bio-indicators to engineered microbial 
biosensors able to recognize a particular analyte 
and transduce it into a detectable response35-38. For 
many years, a large number of biosensors have been 
constructed and implemented in various applications, 
ranging from public health, microbial ecology to 
environmental monitoring and food safety35. Microbial 
biosensors can be classified according to the type 
of signal that is detected after the interaction with 
the analyte including electrochemical39, thermal40, 
acoustic41 and optical biosensors42.
Optical biosensors are the most commercially 
successful by far, and they are mainly based on the 
natural occurrence of bioluminescence observed in 
bacteria such as Vibrio fisheri43. Bioluminescence in the 
luminous marine bacteria Vibrio fisheri was described 
over 33 years ago as a phenome produced by Quorum 
Sensing (QS)44. According to Miller and Bassler QS 
can be defined as the regulation of gene expression 
in response to fluctuation in cell population density45. 
Nowadays, a large number of studies have reported many 
phenotypes under control of Quorum Sensing including 
not only bioluminescence production but modulation of 
virulence factors46, symbiosis establishment47, genetic 
competence48, antibiotic production49, motility50, 
sporulation48 and biofilm formation51. QS Biosensors 
represent an alternative way of identification of several 
QS systems, which have profound implications in the 
healthcare and industry field.
Bioluminescent whole cell biosensors have also been 
developed using synthetic biology approaches since 
they are conceptually simple devices with a real-world 
application43. In addition, the increasing amount of 
input/output modalities available in the MIT Registry of 
Standard Biological Parts and a large number of models 
presented at the iGEM (the International Genetically 
Engineered Machine competition) allow a fairly quickly 
engineering process. The principles, devices, modules 
and methods employed to construct bioluminescent 
biosensors established the basis for designing novel 
biosensors for monitoring water, soil, and air quality.
In developing countries, poor water quality and 
unintentional poisonings are two leading causes of 
environmental diseases with a total of ~3.5 million and 
~600 000 deaths globally per year, respectively (Table 
1). Several synthetic biosensors have designed to 
monitor the quality of water in an expensive, faster and 
the environmental-friendly way52. In general synthetic 
biosensors are composed by a reporter gene (fluorescent, 
luminescent or electrochemical), which is placed under 
the control of a promoter that is activated in the presence 
of a specific water contaminant53. Several biosensors that 
respond to arsenic54, cadmium55, mercury56, nitrogen57, 
ammonium58, nitrate59, phosphorus60 and heavy metals 
have been reported53. These biosensors can detect 
water contaminants with sensitivities comparable to the 
conventional chemical/optical methods53.
One of the contaminants that to date is still circulating in 
groundwater causing more than 230 000 deaths globally 
per year is lead (Table 1). Poisoning by this heavy metal 
remains the world`s most common environmentally 
caused disease61. Remarkably, scientists of the National 
Taiwan University and the University of California 
have developed a highly selective fluorescent biosensor 
for detecting lead in living cells61-62. Authors have 
synthesized a Leadfluor-1 (LF1) turn-on sensor for 
selective detection of Pb2+ in water and living cells. 
Nevertheless, the authors conclude that more research 
is needed to standardize this method and subsequently 
implement it over the world.
In general, most of the current biosensors have been 
engineered in standard laboratory E. coli strains, which 
lack many of their physiological characteristics once 
they are placed in real environments. Consequently, 
most of the current research has shifted to the design 
of synthetic biosensors using native microorganism that 
inhabits the environment of interest53.
Synthetic Biology against climate change
The increase in world’s population, as well as the global 
progressive trend in the development of industries, 
depends on energy in various forms. One important type 
of energy is the petroleum reserves. On the one hand, if 
these reserves are definite and in control of politically 
unstable countries, on the other hand, the use of this 
petro-based energy posed a serious threat to the climate 
in the form of global warming. In developing countries, 
this problem is more severe since there is a scarcity of 
resources to handle its hazardous waste streams. In this 
regard, the synthetic biology can provide a solution and 
has already provided an alternative to fossil fuels in the 
shape of biofuels such as bioethanol.
Bioethanol produced by natural S. cerevisiae strains 
from starch and sugar is the currently largest product 
in industrial biotechnology regarding market volume63. 
However, starch and sugar-containing plant biomass 
for example corn, cassava, sugar beet and sugar 
cane are usually employed as food or fodder64,65. As 
a consequence, the growing demand of industrial 
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biotechnology for carbon sources is feared to result 
in food shortage. Food security strongly requires a 
switch in industrial biotechnology towards renewable 
non-food carbon sources. In this regard, using non-
edible lignocellulosic plant biomass is a possible 
route. Notably, the use of lignocellulose has also 
advantages compared to starch in terms of reduction 
of greenhouse gas emissions as shown by several 
studies in the field of bioethanol66,67. However, the 
utilization of lignocellulosic biomass generates several 
challenges at different levels. They mainly result from 
the complex nature of this feedstock and include (i) 
the requirement of harsh pretreatment methods68, (ii) 
complex and efficient enzyme mixtures for cellulose 
and hemicellulose hydrolysis produced in a cost-
efficient way69,70 plus (iii) microorganisms able to 
efficiently ferment complex sugar mixtures (including 
pentose sugars) in the presence of toxic inhibitors in 
lignocellulosic hydrolysates.
An ideal fermentation organism for industrial 
implementation in lignocellulose-derived ethanol 
production is expected to be able to produce cellulases 
and hemicellulases for the hydrolysis of hemicellulose 
and cellulose to consolidate hydrolysis and fermentation 
steps71. Although there have been many reports 
showing the expression of heterologous cellulolytic 
enzymes (e.g. endoglucanases and beta-glucosidases) 
in S. cerevisiae using synthetic biology approaches, the 
efficiency of cellulose and hemicellulose degradation 
by this way has not been sufficiently developed72-74.
A major challenge for lignocellulose-derived ethanol 
production results from the fact that the hydrolysis 
of lignocellulosic biomass into fermentable sugars 
is accompanied by the release of compounds that are 
inhibitory to microorganisms75. These compounds 
mainly result from degradation of hemicelluloses 
during pre-treatment and enzymatic hydrolysis. 
Different studies have been conducted for both reducing 
microbial inhibitors in the lignocellulosic hydrolysates76 
and improving tolerance thought genetic and metabolic 
engineering.
One of the well-documented advantages of synthetic 
biology is its potential to valorize the waste stream 
from biofuels production. For instance, although the 
CO2 formed as a result of bioethanol formation, can be 
in principle taken up by plants via photosynthesis, but 
recently Schwander and coworkers (2016) developed 
a synthetic metabolic pathway that is even 20% more 
efficient than photosynthesis to fix the CO2 from the 
atmosphere. This technology will be very useful in 
developing countries and especially in those areas 
where the plants cannot grow due to the shortage of 
water or other factors. Another example is the biodiesel 
production via transesterification that generates 10 % 
(w/w) glycerol77. Glycerol can be used as a carbon 
source for growing different kind of engineered 
microorganisms to produce biochemical and proteins. 
One such example is the production of 1,3-propanediol 
from glycerol, which is used in cosmetics, polymers, 
lubricants, foods, and medicines78. 
Another problem that is related to the use of fossil fuels 
is the release of harmful gasses in the air due to its 
combustion in engines. Acquiring expensive equipment 
and their maintenance to detect the levels of these 
harmful gasses in developing countries would not be 
feasible due to high cost. Very recently, a simplified 
biosensor was developed by an iGEM team (iGEM, 
2016. inspector NO.CO.Li, Pakistan) that detects 
the levels of nitrogen oxide and carbon monoxide 
concentrations in the air. Various efforts in biotech sector 
have been dedicated to develop heat, cold, drought, and 
salinity-tolerant crops. These crops are anticipated to 
cope with the aftermath of climate change that results 
from global warming.
Last generation methods for engineering 
biological systems
The term synthetic biology dates back to 191079. The 
first report that is regarded as a landmark in this regard 
was originated around 196180. Later, the so-called 
pre-genomic era started between the 1970s and 1980s 
that mainly include the techniques such as molecular 
cloning and PCR. After this era, the synthetic biology 
field progressed with a faster pace. Especially, during 
the last decade i.e. since the mid of the 1990s, many 
techniques have been developed. For instance, RNAi-
mediated gene knockdown, integration via homologous 
recombination, Zinc finger technology, transcription-
activator-like effector nucleases (TALENs) and homing 
meganucleases. However, most of these methods have 
either low efficiency or results in off-target toxicity. 
Besides they are costly and time-consuming to engineer 
thus limiting their widespread use, particularly its 
application in developing countries where the resources 
are already very limited. Very recently, a new genome 
editing system called CRISPR-Cas9 was introduced 
and its potentiality to edit the genomes of human cells 
has been already reported81. This system has thrilled the 
synthetic biology community, and since then it has been 
used for genetic engineering of a variety of organisms. 
The reasons for its popularity are its accuracy and also 
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the fact that it is cheaper and faster than the previous 
genome editing system. It is anticipated and currently 
seems like it will revolutionize the synthetic biology 
paradigm. The use of CRISPR-Cas9 might need laws 
and regulations in future to make the properly controlled 
use of this technology. These guidelines are regularly 
under development in developed countries. However, 
the formulations of new laws do not always guarantee 
the proper receiving of genetically modified organism-
based products as the inhabitant of different parts of the 
world react differently to the modern biotechnology82. 
The use CRISPR-Cas9 for genome editing of plants 
and microorganisms is already in practice, and biotech 
companies around the world are quickly adopting it. 
The application of genome editing methods is crucial in 
solving the human health problems. In the health area, 
many unresolved health issues still exist in humans 
such as AIDS, hepatitis and different kinds of cancers. 
The transferable disease such is AIDS is creating much 
chaos in developing nations such is in Africa, where 
the awareness of the public and resources to handle 
its epidemic are less. Very recently, the first CRISPR-
Cas9 based clinical trial was attempted in China for 
curing the lung cancer of a patient83. These developing 
countries also face the food shortage problem; that 
can also be addressed by application of these latest 
synthetic biology methods that can create robust crops 
as discussed above. In short, it will take time to reach 
the benefits or the customized CRISPR-Cas9 based 
genome editing methods to developing countries. 
Before its use in a routine way in these countries, laws 
and regulations needed to be developed, implemented 
and strictly observed.
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